Kenneth F. Boehm

Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA.

E2open LLC provides solutions for supply chain management. It serves the pharmaceutical, consumer goods, industrial manufacturing and automotive sectors. The firm’s solutions include channel data management, inventory visibility, sourcing and procurement. The company was founded by John B. Mumford in July 2000 and is headquartered in Austin, TX.

Polycom, Inc. develops video, voice and content collaboration and communication technology. It offers consult, deployment, customer support, optimization, managed and cloud services. The firm serves healthcare, education, entertainment, government and finance industries. It offers solutions through Polycom RealPresence platform. The company was founded by Brian L. Hinman and Jeffrey Rodman in December 1990 and is headquartered in San Jose, CA.

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases

Palmsource, Inc. develops and licenses platform software. It has enhanced its platform with applications such as personal information management software, web browsers and e-mail. A wide range of smart mobile devices incorporate its solutions, including personal digital assistants.